Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 252875-61-9 magea4(230-239) in China, also supports custom service. Welcome to wholesale bulk high quality cas 252875-61-9 magea4(230-239) from our factory. Contact us for more details.
| Description | MAGE-A4 residues 230–239, an HLA-restricted CD8+ epitope; MAGE-A4 is a solid-tumor target for vaccines and TCR-T/CAR-T. |
Product Basic Information Table
| Product Standard English Name | Product Abbreviation / Alias | Function Tags (comma-separated) | Core Structure | Molecular Formula | Exact Mass (Da) | Average MW (Da) | Salt Form | Length (aa) |
| MAGE-A4 (230-239) peptide (GVYDGREHTV, 10-mer, HLA-A2 CTL epitope) | MAGE-A4 230-239; GVYDGREHTV; MAGE-A4 p230-239; MAGEA4 epitope peptide | cancer-testis antigen, MAGE-A4, HLA-A2, CD8+ T cell epitope, CTL epitope, cancer vaccine, TCR-T target, bispecific T cell engager, lung cancer, esophageal cancer, ovarian cancer, head and neck cancer, melanoma, immunogenic peptide | Full sequence H-Gly-Val-Tyr-Asp-Gly-Arg-Glu-His-Thr-Val-OH; single-letter GVYDGREHTV, 10 aa; free N-terminal amine and free C-terminal carboxyl (free acid); linear peptide, no artificial modifications. Sensitive residues: Tyr x1 (light-sensitive oxidation), His x1, Arg x1; no free Cys, no Met, no Trp. | C48H73N15O17 | 1131.53 | 1132.20 | powder; typically TFA salt (residual TFA from RP-HPLC); CAS listed as free peptide; confirm on COA | 10 |
Physicochemical Solubility & Storage Parameters
| Product Code | Appearance | Long-term Storage | Short-term Storage | Solution Stability | Solid Powder Stability |
| PEP-MAGEA4-01 | White to off-white powder | Store desiccated, light-protected and sealed at <= -20 C; expected powder stability 2-3 years | After reconstitution, aliquot into single-use portions and store at -80 C; avoid repeated freeze-thaw (use within ~1 month) | Protect from light due to Tyr. The peptide is relatively hydrophilic (Asp/Glu/Arg/His); soluble in sterile water or PBS, with a small amount of DMSO if needed; gentle sonication helps dissolution. | Keep the powder dry, light-protected and sealed. With no free thiol or methionine, oxidation risk is low, but prolonged moisture uptake should still be avoided. |
Functional Description
| Product Code | Frontend Short Summary | Detailed Biological Function Description | Applicable Research Areas (comma-separated) | Targets / Receptors |
| PEP-MAGEA4-01 | MAGE-A4 (230-239) peptide (CAS 252875-61-9) is the decapeptide GVYDGREHTV derived from melanoma-associated antigen MAGE-A4 (P43358). It is the classic HLA-A2-restricted CD8+ CTL epitope and the core target peptide of MAGE-A4-directed TCR-T and bispecific T-cell-engaging therapies. | MAGE-A4 (melanoma-associated antigen 4, gene MAGEA4, UniProt P43358) belongs to the MAGE-I cancer-testis antigen family. It is essentially absent from normal somatic tissues but frequently expressed in lung (~51%), esophageal (~63%), ovarian, head-and-neck squamous, bladder carcinomas and melanoma, conferring strict tumor specificity. The decapeptide GVYDGREHTV (residues 230-239) was first identified by Dufour et al. in 1999 through autologous CTL cloning; presented by HLA-A2 (A*0201), it is recognized by MAGE-A4-specific CD8+ cytotoxic T lymphocytes that lyse HLA-A2+ MAGE-A4+ tumor cells. This epitope is a central target for solid-tumor TCR-T therapy: engineered TCRs specific for the MAGE-A4 p230-239/HLA-A2 complex (e.g., afamitresgene autoleucel, afami-cel) have shown clinical activity in synovial sarcoma and ovarian cancer. The peptide is widely used for in vitro stimulation of MAGE-A4-specific CD8+ T cells, TCR discovery, tetramer production and potency testing of TCR-T cells and peptide-HLA-targeting TCR-like/bispecific reagents. | tumor immunology, cancer vaccine, T cell epitope mapping, HLA-A2 studies, TCR-T therapy, bispecific antibody, lung cancer, esophageal cancer, ovarian cancer, head and neck cancer, melanoma, synovial sarcoma, CTL killing assay, immune monitoring | HLA-A2 / HLA-A*0201 (MHC class I); CD8+ TCR; MAGE-A4/P43358 |
Hot Tags: cas 252875-61-9 magea4(230-239), China cas 252875-61-9 magea4(230-239) manufacturers, suppliers, factory, 2293841-58-2, 265669-37-2, CAS 124454 83 7, CAS 199727 68 9, CAS 2293841 58 2, Nucleoprotein 118 126
